The idea of a private sector subsidy programme of artemisinin-based combination therapies
(ACTs) was first proposed in 2004. Since then, several countries around the world have …

Background Within the context of increasing antimalarial costs and or decreasing malaria
transmission, the importance of limiting antimalarial treatment to only those confirmed as …

This study aimed to evaluate the economic implications of rapid diagnostic tests (RDTs) on
malaria management through the rational use of artemisinin-based combination therapy …

At the turn of this new century and after much debate, the malaria community reckoned with
failing first line therapies and moved to a global recommendation for deployment of an …

Background Policy makers, governments and donors are faced with an information gap
when considering ways to improve access to artemisinin-based combination therapy (ACT) …

Introduction In many malaria-endemic countries, the private retail sector is a major source of
antimalarial drugs. However, the rarity of malaria diagnostic testing in the retail sector leads …

Whilst some populations have recently experienced dramatic declines in malaria, the
majority of those most at risk of Plasmodium falciparum malaria still lack access to effective …

Background Malaria-endemic countries are switching antimalarial drug policy from cheap
ineffective monotherapies to artemisinin combination therapies (ACTs) for the treatment of …

The Affordable Medicines Facility-malaria is an innovative financing mechanism, managed
by the Global Fund to Fight AIDS, Tuberculosis and Malaria. This initiative aims to increase …

Background To avoid misuse of anti-malarials, correct diagnosis of fever prior to drug
prescription is essential. Presumptive treatment in the private healthcare sector is a concern …